Summary: This week we review a recent work on the prevalence of adverse events when starting sotalol in the pediatric patient with arrhythmias. How commonly were problems encountered? Does initiation always require hospitalization and monitoring in an inpatient setting or are there some patients who might be candidates for an outpatient approach? Is there a level of dysfunction that would preclude its use? Assistant Professor of Pediatrics at Northwestern University, Dr. Stephanie Chandler, provides insights into her work from the group at Boston Children's Hospital. Also featured is a brief discussion with Dr. Jack Rychik of Children's Hospital of Philadelphia regarding the CHOP2020 course and next year's CHOP2021. doi: 10.1016/j.hrthm.2020.01.022
